项目编号 PRJCA004965
项目标题 Tumor evolution selectively inactivates the core microRNA machinery for immune evasion
涉及领域 Medical
数据类型 Transcriptome or Gene expression
Raw sequence reads
物种名称 Mus musculus
描述信息 Cancer cells acquire genetic heterogeneity to escape from immune surveillance during tumor evolution, but a systematic approach to distinguish emerging driver from passenger mutations is lacking. Here we investigate the impact of different immune pressure on tumor clonal dynamics and immune evasion mechanism by combining massive parallel sequencing of immune edited murine tumors and targeted CRISPR library screens in xenograft and co-culture systems. We find that the activity of the core microRNA (miRNA) biogenesis and targeting machinery maintains the sensitivity of cancer cells to PD-1-independent T cell-mediated cytotoxicity. Inactivation of the machinery or introduction of its frequent mutations found in patients dampens the JAK-STAT-interferon-γ signaling, chemokine expression and antigen presentation in cancer cells, largely by abolishing miRNA-targeted silencing of suppressor of cytokine signaling 1 (SOCS1). In nearly all human cancer types, expression of each miRNA machinery component strongly correlates with intratumoral T cell infiltration. Our data indicate that the evolutionarily conserved miRNA pathway is exploited by cancer cells for escape from immune elimination and T cell-based immunotherapy.
样品范围 Multiisolate
发布日期 2021-09-15
出版信息
PubMed ID 文章标题 杂志名称 Doi 发表年份
34853298 Tumor evolution selectively inactivates the core microRNA machinery for immune evasion Nature Communications 10.1038/s41467-021-27331-3 2021
实验材料提供者 Cang Yong Lab
项目资金来源
机构 项目类型 授权项目ID 授权项目名称
National Natural Science Foundation of China (NSFC) Young Scientists Fund 82003803
China Postdoctoral Science Foundation 2020T130669
China Postdoctoral Science Foundation 2019M651613
提交者 Tian-Yu Song (songtianyu@zju.edu.cn)
提交单位 ShanghaiTech University
提交日期 2021-05-07

项目包含数据信息

资源名称 描述
BioSample (103)  show -
GSA (4) -
CRA004141 RNASeq for Clonal Mutation Profiling
CRA004140 RNASeq of Ankrd52 KO MC38 tumor cells
CRA004145 T cell co-culture CRISPR screen targeting profiled tumor heterogeneity
CRA004146 In vivo CRISPR screen targeting profiled tumor heterogeneity